Latest News

 Filter by Provider

The tokenized equity market is expanding so quickly that some of the most likely future leaders haven't had time to put their boots on yet.

Persistent inflation tied to the Iran war has made further interest rate hikes more likely.

The "Oracle of Omaha" has simple advice for anxious investors.

Buying low and selling high isn't always the best strategy.

Social Security’s biggest raise in years is here, but it may be too little and too late for many retirees.

Sandisk and Micron are shifting their business models.

He boasted that SpaceX SI is "a bit like the New York Yankees playing in Little League."

The public feud between President Trump and the central bank may be heating up.

Palantir has a lot of growth priced into its stock.

The consumer tech leader has been a winning investment over the long term.

CapsoVision (NASDAQ:CV) outlined its strategy to expand capsule endoscopy technology beyond its current small-bowel business into colon, pancreatic and esophageal cancer screening applications, highlighting its artificial intelligence capabilities, cloud-based workflow and upcoming regulatory submis

AI has a storage problem. That gives Seagate a role investors should understand.

Pfizer has a plan to bounce back from recent obstacles.

Lexeo Therapeutics (NASDAQ:LXEO) outlined its approach to evaluating LX2020, an investigational AAVrh10-based gene therapy for PKP2-associated arrhythmogenic cardiomyopathy, or ACM, ahead of an expected clinical and regulatory update later this quarter. CEO Nolan Townsend said PKP2 ACM is a serious

Just a few months ago, they were shorting it.

Space Exploration Technologies' stock price is rallying after earnings, but the most meaningful gains for shareholders won't come from just one quarterly report.

$4.5 billion in available capital gives management flexibility to fund growth and return cash to shareholders as freight conditions stabilize.

If you are a long-term investor with 10 to 20 years ahead of you, there's a good chance you will run into a market crash at some point.

BlockchAIn Digital Infrastructure (NYSEAMERICAN:AIB) outlined a data-center development strategy centered on smaller, power-secured facilities, long-term tenant contracts and project-level financing during a presentation by CFO Jolienne Halisky. Halisky said the company views itself as a “right-siz

OpenAI dialed back its initial aim for a $1.5 trillion.

XRP has already gone parabolic three times. Here's how it could happen yet again.

Sales growth is only part of the story for one of the leading AI labs, which is expected to go public this year.

You can't go wrong with either, but one seems to have more runway.

Kits Eyecare (TSE:KITS) is targeting further growth in the online optical market by expanding its higher-margin glasses business, increasing brand awareness through select physical locations and leveraging a manufacturing operation that management says has substantial unused capacity. Speaking at a

Has the AI boom already peaked?

Vertex Pharmaceuticals (NASDAQ:VRTX) outlined updates across its kidney disease pipeline at the American Society of Nephrology Kidney Week 2026, highlighting data for povetacicept in IgA nephropathy and inaxaplin in APOL1-mediated kidney disease, or AMKD. Chief Executive Officer and President Reshm

SpaceX delivered a stronger quarter than I expected. But its accelerating AI spending leaves shareholders with a very expensive question.

Novartis (NYSE:NVS) presented Phase III results for remibrutinib in relapsing multiple sclerosis, reporting that the oral Bruton’s tyrosine kinase inhibitor reduced relapse rates and MRI lesion activity versus teriflunomide in the REMODEL-1 and REMODEL-2 studies. The company said global regulatory

Analyze the current issues impacting data centres, from AI investment strategies to concerns reminiscent of past financial crises.

Canadian utility stocks report soon. See what Fortis, Emera and Canadian Utilities investors should consider before buying ahead of earnings.

The hard drive maker's growth keeps speeding up. Has the stock's slide gone too far?

Explore the advantages of a TFSA and discover how selecting the ideal TFSA stock can maximize your investment returns.

Tourmaline's costs, market access, and planned dividend increase provide a more durable investment case than referendum relief.

Vinci Compass Investments (NASDAQ:VINP) said it plans to launch Vinci Permanent Capital Solutions, or VPCS, through the acquisition of AustralRe, a Latin American reinsurance platform that Vinci helped found in 2011. The transaction is expected to close in the first quarter of 2027, subject to regu

Crombie REIT offers a dependable yield and a low payout ratio. Discover why it’s a top choice for monthly retirement income.

SpaceX could be a bigger threat than investors expected.

One is a growth stock but faces Pepsi dependency; the other is a more mature company but has massive operating cash flow.

Canadian bank stocks offer different buying cases in late 2026. Compare Scotiabank, TD and Royal Bank on income, earnings and execution risks.

While geopolitical uncertainties and commodity price volatility remain potential risks, Enbridge’s Q3 outlook remains strong.

Need $500 a month tax free? At a 6.9% yield, about $87,000 in a TFSA could do it. See how SmartCentres REIT and Automotive Properties REIT fit in the plan.

Here’s a 5% dividend stock that can generate $100 every month from a large portfolio of real estate properties spread across Canada.

Beware that re‑contributing withdrawn funds in the same calendar year can lead to a penalty from potential excess contribution.

TFSA users can prepare for year-end by checking contribution room, putting long-term cash to work and reviewing diversification with three ETFs.

A refund or bonus could bring your emergency fund months closer to completion and give your investments more time to grow.